Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits

被引:19
作者
Fujii, J [1 ]
Kinoshita, Y
Yamada, Y
Yutsudo, T
Kita, T
Takeda, T
Yoshida, S
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Microbiol, Kitakyushu, Fukuoka 8078555, Japan
[2] Univ Occupat & Environm Hlth, Sch Med, Dept Neurosurg, Kitakyushu, Fukuoka 8078555, Japan
[3] Univ Occupat & Environm Hlth, Sch Med, Dept Urol, Kitakyushu, Fukuoka 8078555, Japan
[4] Univ Occupat & Environm Hlth, Sch Med, Dept Forens Med, Kitakyushu, Fukuoka 8078555, Japan
[5] Shionogi & Co Ltd, Antibacterial Program, Discovery Res Labs 2, Osaka 5610825, Japan
[6] Natl Childrens Med Res Ctr, Dept Infect Dis Res, Tokyo 1540004, Japan
关键词
Stx2 (Shiga toxin 2); Shiga toxin (Stx)-producing E-coli; central nervous system; blood-brain barrier; cerebrospinal fluid-brain barrier;
D O I
10.1006/mpat.1998.0220
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The initial brain lesions in rabbits given intravenous Shiga toxin 2 (Stx2) were noted at 24 h in an area around the third ventricle (Fujii et al., Infect Immun 1996, 64: 5053-60). This result implied that Stx2 is present in the cerebrospinal fluid (CSF) despite the fact that the toxin was administered intravenously. We measured Stx2 activity in CSF by using a Vero cell cytotoxicity assay at various times after an intravenous injection of Stx2. Stx2 was detected from 2 h after the injection, and its concentration in CSF remained at a high level for a further 6 h. Fifty percent lethal doses (LD50) of Stx2 were measured in rabbits after intravenous and intrathecal Stx2 injections; The LD50 after an intrathecal injection of Stx2 was 0.36 mu g/kg, which was 9.2-fold lower than that of an intravenous injection of Stx2 (3.4 mu g/kg). Magnetic resonance images obtained after an intrathecal Stx2 injection (5 mu g/kg) were compared with those obtained after an intravenous Stx2 injection (5 mu g/kg). At 48 h, the cerebellar lesions had spread from the area in contact with the CSF on a T2-weighted image, which suggests that the intrathecal Stx2 may invade the cerebellum directly. We then examined whether anti-Stx2 antiserum injected intrathecally protects rabbits against brain damage. Eighty percent of the rabbits infected with Stx2 at 5 mu g/kg died within 8 days from brain damage. Rabbit anti-Stx2 sera (with titres of x 16 and x 64 by the Ouchterlony precipitation method) were administered into the CSF space through the cisterna magna. All the rabbits (n = 10) survived when they were given an intrathecal injection of rabbit anti-Stx2 antiserum 2 h before the intravenous injection of Stx2. Our results suggest that a leakage of Stx2 into the CSF from the choroid plexus causes brain damage, and that an intrathecal injection of anti-Stx2 antiserum could be a therapy for acute encephalopathy caused by Stx2-producing Escherichia coli. (C) 1998 Academic Press
引用
收藏
页码:139 / 146
页数:8
相关论文
共 23 条
[1]   A PHASE-I STUDY OF CHEMICALLY SYNTHESIZED VEROTOXIN (SHIGA-LIKE TOXIN) PK-TRISACCHARIDE RECEPTORS ATTACHED TO CHROMOSORB FOR PREVENTING HEMOLYTIC-UREMIC SYNDROME [J].
ARMSTRONG, GD ;
ROWE, PC ;
GOODYER, P ;
ORRBINE, E ;
KLASSEN, TP ;
WELLS, G ;
MACKENZIE, A ;
LIOR, H ;
BLANCHARD, C ;
AUCLAIR, F ;
THOMPSON, B ;
RAFTER, DJ ;
MCLAINE, PN .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :1042-1045
[2]  
DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520
[3]   DIRECT EVIDENCE OF NEURON IMPAIRMENT BY ORAL INFECTION WITH VEROTOXIN-PRODUCING ESCHERICHIA-COLI-O157-H- IN MITOMYCIN-TREATED MICE [J].
FUJII, J ;
KITA, T ;
YOSHIDA, SI ;
TAKEDA, T ;
KOBAYASHI, H ;
TANAKA, N ;
OHSATO, K ;
MIZUGUCHI, Y .
INFECTION AND IMMUNITY, 1994, 62 (08) :3447-3453
[4]   Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2 [J].
Fujii, J ;
Kinoshita, Y ;
Kita, T ;
Higure, A ;
Takeda, T ;
Tanaka, N ;
Yoshida, S .
INFECTION AND IMMUNITY, 1996, 64 (12) :5053-5060
[5]   NEUROLOGICAL MANIFESTATIONS OF HEMORRHAGIC COLITIS IN THE OUTBREAK OF ESCHERICHIA-COLI O157-H7 INFECTION IN JAPAN [J].
HAMANO, S ;
NAKANISHI, Y ;
NARA, T ;
SEKI, T ;
OHTANI, T ;
OISHI, T ;
JOH, K ;
OIKAWA, T ;
MURAMATSU, Y ;
OGAWA, Y ;
AKASHI, S .
ACTA PAEDIATRICA, 1993, 82 (05) :454-458
[6]   NUCLEOTIDE-SEQUENCE ANALYSIS OF THE STRUCTURAL GENES FOR SHIGA-LIKE TOXIN-1 ENCODED BY BACTERIOPHAGE-933J FROM ESCHERICHIA-COLI [J].
JACKSON, MP ;
NEWLAND, JW ;
HOLMES, RK ;
OBRIEN, AD .
MICROBIAL PATHOGENESIS, 1987, 2 (02) :147-153
[7]   INFECTION BY VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI [J].
KARMALI, MA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (01) :15-38
[8]   VIRULENCE OF ENTEROHEMORRHAGIC ESCHERICHIA-COLI O91-H21 CLINICAL ISOLATES IN AN ORALLY INFECTED-MOUSE MODEL [J].
LINDGREN, SW ;
MELTON, AR ;
OBRIEN, AD .
INFECTION AND IMMUNITY, 1993, 61 (09) :3832-3842
[9]   VEROTOXIN PRODUCTION AMONG PORCINE STRAINS OF ESCHERICHIA-COLI AND ITS ASSOCIATION WITH EDEMA DISEASE [J].
LINGGOOD, MA ;
THOMPSON, JM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1987, 24 (04) :359-362
[10]  
LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834